BMO Capital Downgrades Vitae Pharmaceuticals (VTAE) to Market Perform Sep 15, 2016 07:10AM
Notable Analyst Rating Changes 4/12: (CHK) (YNDX) (HLX) Upgraded; (AZN) (SBUX) (LB) Downgraded Apr 12, 2016 10:32AM
BMO Capital Starts Vitae Pharmaceuticals (VTAE) at Outperform Apr 11, 2016 04:17PM
Vitae Pharmaceuticals Closes Public Offering of Common Stock Mar 30, 2016 04:05PM
Vitae Pharmaceuticals (VTAE) Prices 5.83M Shares at $6 Mar 24, 2016 09:01AM


Mar 24, 2016 09:00AM Vitae Pharmaceuticals Prices Public Offering of Common Stock
Mar 23, 2016 04:02PM Vitae Pharmaceuticals (VTAE) Announces Common Stock Offering
Mar 23, 2016 04:01PM Vitae Pharmaceuticals Proposes Public Offering of Common Stock
Jan 28, 2015 04:05PM Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Follow-on Public Offering of Common Stock
Jan 23, 2015 07:21AM Vitae Pharmaceuticals (VTAE) Prices 3M Common Follow-On at $11.90/Share
Jan 23, 2015 07:20AM Vitae Pharmaceuticals Announces Pricing of Follow-on Public Offering of Common Stock
Jan 20, 2015 08:00AM Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering of Common Stock
Oct 28, 2014 12:51PM Unusual 11 Mid-Day Movers 10/28: (RCPT) (VDSI) (SANM) Higher; (IBIO) (AMKR) (DCO) Lower
Oct 27, 2014 04:10PM Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares of Initial Public Offering
Oct 20, 2014 09:13AM UPDATE: BMO Capital Starts Vitae Pharmaceuticals (VTAE) at Outperform
Sep 29, 2014 10:35AM Vitae Pharmaceuticals Announces Closing of Initial Public Offering
Sep 24, 2014 11:20AM Vitae Pharmaceuticals (VTAE) IPO Opens Flat